READER; John Charles

Patent Applications and Registrations

Patent applications and USPTO patent grants for READER; John Charles.The latest application filed is for "pharmaceutical compounds".

Company Profile

3.17.18

READER; John Charles - Cambridge GB
READER; John Charles - Cambridgeshire GB
READER; John Charles - Linton GB
- Cambridge GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical Compounds App 20210401809 - READER; John Charles	2021-12-30
Tyk2 Kinase Inhibitors App 20210387981 - READER; John Charles	2021-12-16
Pharmaceutical compounds Grant 11,154,539 - Reader October 26, 2	2021-10-26
Pharmaceutical Compounds App 20210087154 - READER; John Charles	2021-03-25
Pharmaceutical compounds Grant 10,882,829 - Reader January 5, 2	2021-01-05
Pharmaceutical Compounds App 20190350905 - READER; John Charles	2019-11-21
Pharmaceutical Compounds App 20190210983 - READER; John Charles	2019-07-11
5-(Pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic use Grant 9,765,059 - Collins , et al. September 19, 2	2017-09-19
5-(Pyridin-2-yl-Amino)-Pyrazine-2-Carbonitrile Compounds and Their Therapeutic Use App 20160304493 - Collins; Ian ; et al.	2016-10-20
5-(pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic use Grant 9,403,797 - Collins , et al. August 2, 2	2016-08-02
Oxazole tyrosine kinase inhibitors Grant 9,187,465 - Reader , et al. November 17, 2	2015-11-17
Aurora and FLT3 kinases modulators Grant 9,133,180 - Reader September 15, 2	2015-09-15
5-(Pyridin-2-yl-Amino)-Pyrazine-2-Carbonitrile Compounds and Their Therapeutic Use App 20150225372 - Collins; Ian ; et al.	2015-08-13
5-(pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic use Grant 9,040,540 - Collins , et al. May 26, 2	2015-05-26
Oxazole Tyrosine Kinase Inhibitors App 20150057282 - READER; John Charles ; et al.	2015-02-26
Aurora And Flt3 Kinases Modulators App 20150018367 - Reader; John Charles	2015-01-15
Oxazole tyrosine kinase inhibitors Grant 8,921,544 - Reader , et al. December 30, 2	2014-12-30
5-(Pyridin-2-yl-Amino)-Pyrazine-2-Carbonitrile Compounds and Their Therapeutic Use App 20140315925 - Collins; Ian ; et al.	2014-10-23
Oxazole Tyrosine Kinase Inhibitors App 20140275041 - READER; John Charles ; et al.	2014-09-18
9H-pyrimido[4,5-B]indoles, 9H-pyrido[4',3':4,5]pyrrolo[2,3-D]pyridines, and 9H 1,3,6,9 tetraaza-fluorenes as CHK1 kinase function inhibitors Grant 08618121 -	2013-12-31
9H-pyrimido[4,5-B]indoles, 9H-pyrido[4',3':4,5]pyrrolo[2,3-D]pyridines, and 9H 1,3,6,9 tetraaza-fluorenes as CHK1 kinase function inhibitors Grant 8,618,121 - Collins , et al. December 31, 2	2013-12-31
Bicyclylaryl-aryl-amine compounds and their use Grant 8,530,468 - Collins , et al. September 10, 2	2013-09-10
Pharmaceutical Compounds App 20130231340 - READER; John Charles	2013-09-05
Oxazole Tyrosine Kinase Inhibitors App 20130102592 - READER; John Charles ; et al.	2013-04-25
Oxazole tyrosine kinase inhibitors Grant 8,378,095 - Reader , et al. February 19, 2	2013-02-19
Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use Grant 8,367,658 - Collins , et al. February 5, 2	2013-02-05
Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine Compounds and Their Use App 20120040967 - Collins; Ian ; et al.	2012-02-16
Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use Grant 8,058,045 - Collins , et al. November 15, 2	2011-11-15
Bicyclylaryl-aryl-amine Compounds And Their Use App 20100331328 - Collins; Ian ; et al.	2010-12-30
Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine Compounds and Their Use App 20100311730 - Collins; Ian ; et al.	2010-12-09
Oxazole Tyrosine Kinase Inhibitors App 20100298301 - Reader; John Charles ; et al.	2010-11-25
9h-pyrimido[4,5-b]indoles, 9h-pyrido[4',3':4,5]pyrrolo[2,3-d]pyridines, And 9h 1,3,6,9 Tetraaza-fluorenes As Chk1 Kinase Function Inhibitors App 20100210639 - Collins; Ian ; et al.	2010-08-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.